Summary by Moomoo AI
On July 22, 2024, Akeso (Cayman) Limited announced that Dr. Bing C. Wang has been appointed as the company's Chief Financial Officer. Dr. Wang has extensive experience in global strategic investment in the biopharmaceutical field, corporate financing, financial management, and business development. He previously served as the Chief Financial Officer of Cellectis S.A. and was a co-founder and CEO of Refuge Biotechnologies, Inc. In addition, Dr. Wang has also served as a director in the healthcare investment banking division of Barclays Capital USA and is a member of the Columbia Business School Healthcare and Pharmaceutical Management Program Advisory Committee. He holds degrees from Columbia University and Princeton University. The board of directors of Akeso warmly welcomes Dr. Wang's joining and looks forward to his contribution to the company's vision and mission.